Gastroenterology
Volume 134, Issue 7 , Pages 1961-1971.e4 , June 2008

Regulation of Wnt Signaling by the Nuclear Pore Complex

Received 2 November 2007 ,Accepted 7 March 2008.

References 

  1. Peifer M, Polakis P. Wnt signaling in oncogenesis and embryogenesis—a look outside the nucleus. Science. 2000;287:1606–1609
  2. Kikuchi A. Tumor formation by genetic mutations in the components of the Wnt signaling pathway. Cancer Sci. 2003;94:225–229
  3. Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med. 2004;10:789–799
  4. Aberle H, Bauer A, Stappert J, et al. β-Catenin is a target for the ubiquitin-proteasome pathway. EMBO J. 1997;16:3797–3804
  5. Polakis P. Wnt signaling and cancer. Genes Dev. 2000;14:1837–1851
  6. Yamada T, Takaoka AS, Naishiro Y, et al. Transactivation of the multidrug resistance 1 gene by T-cell factor 4/β-catenin complex in early colorectal carcinogenesis. Cancer Res. 2000;60:4761–4766
  7. Wong NA, Pignatelli M. β-Catenin—a linchpin in colorectal carcinogenesis?. Am J Pathol. 2002;160:389–401
  8. Fagotto F, Gluck U, Gumbiner BM. Nuclear localization signal-independent and importin/karyopherin-independent nuclear import of β-catenin. Curr Biol. 1998;8:181–190
  9. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell. 1996;87:159–170
  10. Ilyas M, Tomlinson IP, Rowan A, et al. β-Catenin mutations in cell lines established from human colorectal cancers. Proc Natl Acad Sci U S A. 1997;94:10330–10334
  11. Sparks AB, Morin PJ, Vogelstein B, et al. Mutational analysis of the APC/β-catenin/Tcf pathway in colorectal cancer. Cancer Res. 1998;58:1130–1134
  12. Morin PJ, Sparks AB, Korinek V, et al. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science. 1997;275:1787–1790
  13. Korinek V, Barker N, Moerer P, et al. Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat Genet. 1998;19:379–383
  14. van de Wetering M, Sancho E, Verweij C, et al. The β-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell. 2002;111:241–250
  15. Korinek V, Barker N, Morin PJ, et al. Constitutive transcriptional activation by a β-catenin-Tcf complex in APC−/− colon carcinoma. Science. 1997;275:1784–1787
  16. Idogawa M, Yamada T, Honda K, et al. Poly(ADP-ribose) polymerase-1 is a component of the oncogenic T-cell factor-4/β-catenin complex. Gastroenterology. 2005;128:1919–1936
  17. Shitashige M, Naishiro Y, Idogawa M, et al. Involvement of splicing factor-1 in β-catenin/T-cell factor-4-mediated gene transactivation and pre-mRNA splicing. Gastroenterology. 2007;132:1039–1054
  18. Idogawa M, Masutani M, Shitashige M, et al. Ku70 and poly(ADP-ribose) polymerase-1 competitively regulate β-catenin and T-cell factor-4-mediated gene transactivation: possible linkage of DNA damage recognition and Wnt signaling. Cancer Res. 2007;67:911–918
  19. Huang L, Shitashige M, Satow R, et al. Functional interaction of DNA topoisomerase IIα with the β-catenin and T-cell factor-4 complex. Gastroenterology. 2007;133:1569–1578
  20. Hara T, Honda K, Shitashige M, et al. Mass spectrometry analysis of the native protein complex containing actinin-4 in prostate cancer cells. Mol Cell Proteomics. 2007;6:479–491
  21. Rangasamy D, Wilson VG. Bovine papillomavirus E1 protein is sumoylated by the host cell Ubc9 protein. J Biol Chem. 2000;275:30487–30495
  22. Yokoyama N, Hayashi N, Seki T, et al. A giant nucleopore protein that binds Ran/TC4. Nature. 1995;376:184–188
  23. Joseph J, Tan SH, Karpova TS, et al. SUMO-1 targets RanGAP1 to kinetochores and mitotic spindles. J Cell Biol. 2002;156:595–602
  24. Cheng J, Wang D, Wang Z, et al. SENP1 enhances androgen receptor-dependent transcription through desumoylation of histone deacetylase 1. Mol Cell Biol. 2004;24:6021–6028
  25. Honda K, Yamada T, Hayashida Y, et al. Actinin-4 increases cell motility and promotes lymph node metastasis of colorectal cancer. Gastroenterology. 2005;128:51–62
  26. Sato S, Idogawa M, Honda K, et al. β-Catenin interacts with the FUS proto-oncogene product and regulates pre-mRNA splicing. Gastroenterology. 2005;129:1225–1236
  27. Rout MP, Aitchison JD. The nuclear pore complex as a transport machine. J Biol Chem. 2001;276:16593–16596
  28. Koepp DM, Silver PA. A GTPase controlling nuclear trafficking: running the right way or walking RANdomly?. Cell. 1996;87:1–4
  29. Mahajan R, Delphin C, Guan T, et al. A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell. 1997;88:97–107
  30. Reverter D, Lima CD. Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-Nup358 complex. Nature. 2005;435:687–692
  31. Tatham MH, Kim S, Jaffray E, et al. Unique binding interactions among Ubc9, SUMO, and RanBP2 reveal a mechanism for SUMO paralog selection. Nat Struct Mol Biol. 2005;12:67–74
  32. Melchior F, Schergaut M, Pichler A. SUMO: ligases, isopeptidases and nuclear pores. Trends Biochem Sci. 2003;28:612–618
  33. Seeler JS, Dejean A. Nuclear and unclear functions of SUMO. Nat Rev Mol Cell Biol. 2003;4:690–699
  34. Pichler A, Gast A, Seeler JS, et al. The nucleoporin RanBP2 has SUMO1 E3 ligase activity. Cell. 2002;108:109–120
  35. Hang J, Dasso M. Association of the human SUMO-1 protease SENP2 with the nuclear pore. J Biol Chem. 2002;277:19961–19966
  36. Pichler A, Melchior F. Ubiquitin-related modifier SUMO1 and nucleocytoplasmic transport. Traffic. 2002;3:381–387
  37. Tran EJ, Wente SR. Dynamic nuclear pore complexes: life on the edge. Cell. 2006;125:1041–1053
  38. Patel SS, Belmont BJ, Sante JM, et al. Natively unfolded nucleoporins gate protein diffusion across the nuclear pore complex. Cell. 2007;129:83–96
  39. Matunis MJ, Coutavas E, Blobel G. A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex. J Cell Biol. 1996;135:1457–1470
  40. Zhang H, Saitoh H, Matunis MJ. Enzymes of the SUMO modification pathway localize to filaments of the nuclear pore complex. Mol Cell Biol. 2002;22:6498–6508
  41. Hendriksen J, Fagotto F, van der Velde H, et al. RanBP3 enhances nuclear export of active β-catenin independently of CRM1. J Cell Biol. 2005;171:785–797
  42. Joseph J, Liu ST, Jablonski SA, et al. The RanGAP1-RanBP2 complex is essential for microtubule-kinetochore interactions in vivo. Curr Biol. 2004;14:611–617
  43. Mo YY, Moschos SJ. Targeting Ubc9 for cancer therapy. Expert Opin Ther Targets. 2005;9:1203–1216
  44. Mo YY, Yu Y, Theodosiou E, et al. A role for Ubc9 in tumorigenesis. Oncogene. 2005;24:2677–2683
  45. Yamamoto H, Ihara M, Matsuura Y, et al. Sumoylation is involved in β-catenin-dependent activation of Tcf-4. EMBO J. 2003;22:2047–2059

 Supported by the “Program for Promotion of Fundamental Studies in Health Sciences” conducted by the National Institute of Biomedical Innovation of Japan; the “Third-Term Comprehensive Control Research for Cancer” conducted by the Ministry of Health, Labor, and Welfare of Japan and the Ministry of Education, Culture, Sports, Science, and Technology of Japan; and grants from the Naito Foundation, the Princess Takamatsu Cancer Research Fund, and the Foundation for the Promotion of Cancer Research.

 Conflicts of interest: Nothing to be declared.

PII: S0016-5085(08)00445-9

doi: 10.1053/j.gastro.2008.03.010

Gastroenterology
Volume 134, Issue 7 , Pages 1961-1971.e4 , June 2008

Article Tools

* Image Usage & Resolution